<DOC>
	<DOCNO>NCT00575367</DOCNO>
	<brief_summary>The purpose study evaluate drug concentration AzaSite compare Vigamox tear healthy volunteer</brief_summary>
	<brief_title>Study AzaSite Versus Vigamox Tears Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Have visual acuity , use corrective lens ( contact lens ) necessary , eye least +0.7 assess Early Treatment Diabetic Retinopathy Study . Have normal lid anatomy . Have abnormal biomicroscopy ophthalmoscopy exam . Have diagnosis dry eye disease experience dry eye symptom ( photophobia , foreign body sensation , itching , burning , pain , dry grittiness ) past thirty day . Have use artificial tear past thirty day . Have diagnosis ongoing ocular infection lid margin inflammation . Have ever penetrate ocular surface intraocular surgery . Have know hypersensitivity azithromycin , macrolide antibiotic ingredient AzaSite . Have know hypersensitivity Vigamox fluoroquinolone antibiotic ingredient Vigamox . Have corneal lid abnormality . Have glaucoma , Intra Ocular Pressure 22 mm Hg great one eye . Have ocular pathology exception cataract . Have serious systemic disease uncontrolled medical condition . Have experience symptom viral allergic conjunctivitis past 30 day . Have history liver kidney disease result persist dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>